Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04684693
Other study ID # REC/010-2020
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date December 25, 2020
Est. completion date January 22, 2021

Study information

Verified date December 2020
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Studying the effect of laser puncture on rheumatoid arthritis patients


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 60
Est. completion date January 22, 2021
Est. primary completion date January 20, 2021
Accepts healthy volunteers No
Gender All
Age group 65 Years to 75 Years
Eligibility Inclusion Criteria: - Meeting the criteria of ACR classification for rheumatoid arthritis - Meeting the criteria of EULAR classification for rheumatoid arthritis Exclusion Criteria: - Having malignancy - Having connective tissue disease - Smokers

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Laser
Laser puncture and exercise
Procedure:
Control
Exercise

Locations

Country Name City State
Egypt M. Sedky Cairo

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary HAQ (Change) Health Assessment questionnaire Pre-intervention, 4 weeks
Primary RAQoL (Change) Rheumatoid Arthritis Quality of Life Pre-intervention, 4 weeks
Primary CRP (Change) Analysis of serum C-reactive protein Pre-intervention, 4 weeks
Primary IL-6 (Change) Plasma interleukin-6 inflammatory markers Pre-intervention, 4 weeks
Primary ATP (Change) Plasma ATP concentration anti-oxidant marker Pre-intervention, 4 weeks
Primary MDA (Change) plasma malondialdehyde oxidative marker Pre-intervention, 4 weeks
See also
  Status Clinical Trial Phase
Completed NCT04226131 - MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics N/A
Completed NCT04171414 - A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis Phase 3
Completed NCT02833350 - Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA) Phase 2
Completed NCT04255134 - Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN) Phase 4
Recruiting NCT05615246 - Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
Completed NCT03248518 - Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases N/A
Completed NCT03514355 - MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms N/A
Recruiting NCT06005220 - SBD121, a Synbiotic Medical Food for RA Management N/A
Recruiting NCT05451615 - Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis Phase 3
Completed NCT05054920 - Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis N/A
Completed NCT02037737 - Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting N/A
Recruiting NCT04079374 - Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel Phase 3
Completed NCT02504268 - Effects of Abatacept in Patients With Early Rheumatoid Arthritis Phase 3
Recruiting NCT05496855 - Remote Care in People With Rheumatoid Arthritis N/A
Completed NCT05051943 - A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
Recruiting NCT06103773 - A Study of Single and Multiple Oral Doses of TollB-001 Phase 1
Recruiting NCT06031415 - Study of GS-0272 in Participants With Rheumatoid Arthritis Phase 1
Completed NCT05999266 - The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
Recruiting NCT05302934 - Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
Recruiting NCT04169100 - Novel Form of Acquired Long QT Syndrome Phase 4